Table 3.
Patient demographics based on weight change from Cycle 1 to 2
| Weight gain (N = 208) | Weight loss <2.0% (N = 225) | Weight loss >2.0% (N = 223) | P value | |
|---|---|---|---|---|
| Age | 0.9199 a | |||
| Mean (SD) | 66.2 (10.15) | 66.2 (10.12) | 65.7 (10.38) | |
| Median (range) | 67 (38, 91) | 67 (33, 91) | 67 (37, 90) | |
| Sex, n (%) | 0.5782 b | |||
| Female | 87 (41.8) | 85 (37.8) | 94 (42.2) | |
| Male | 121 (58.2) | 140 (62.2) | 129 (57.8) | |
| Race, n (%) | 0.8360 b | |||
| White | 185 (96.9) | 182 (94.3) | 177 (95.2) | |
| Other | 6 (3.1) | 11 (5.7) | 9 (4.8) | |
| Missing | 17 | 32 | 37 | |
| Baseline BMI | 0.1543 a | |||
| Mean (SD) | 25.9 (4.86) | 27.0 (5.95) | 26.8 (5.15) | |
| Median (range) | 25.4 (15.1, 41.6) | 26.2 (15.8, 47.0) | 26.5 (15.5, 48.0) | |
| Baseline BMI category, n (%) | 0.1149 b | |||
| Normal weight | 84 (41.2) | 82 (37.4) | 66 (32.0) | |
| Obese | 34 (16.7) | 56 (25.6) | 45 (21.8) | |
| Overweight | 77 (37.7) | 74 (33.8) | 90 (43.7) | |
| Underweight | 9 (4.4) | 7 (3.2) | 5 (2.4) | |
| Missing | 4 | 6 | 17 | |
| Performance score, n (%) | 0.2782 b | |||
| 0 | 95 (45.7) | 97 (43.1) | 83 (37.2) | |
| 1 | 103 (49.5) | 120 (53.3) | 125 (56.1) | |
| 2 | 10 (4.8) | 8 (3.6) | 15 (6.7) | |
| Disease stage, n (%) | 0.1730 b | |||
| IIIA | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| IIIB | 32 (16.1) | 41 (19.2) | 29 (13.6) | |
| IV | 164 (82.4) | 171 (80.3) | 184 (86.4) | |
| Other | 3 (1.5) | 1 (0.5) | 0 (0.0) | |
| Missing | 9 | 12 | 10 | |
BMI, body mass index; SD, standard deviation.
a
Kruskal–Wallis P value.
b
χ2 P value.